Guardant Health (GH) Net Cash Flow (2017 - 2026)

Guardant Health has disclosed Net Cash Flow across 10 years of filings, most recently posting $612.2 million for Q1 2026.

• Net Cash Flow for Q1 2026 came in at $612.2 million, up 253.22% year-over-year; the trailing twelve-month figure through Mar 2026 was $298.1 million (up 191.56% YoY), and the FY2025 annual result was -$140.8 million, up 71.96% from the prior year.
• Net Cash Flow came in at $612.2 million for Q1 2026 at Guardant Health, up from -$199.4 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $675.3 million in Q4 2023 to a low of -$356.9 million in Q2 2022.
• The 5-year median for Net Cash Flow is -$17.8 million (2022), against an average of $36.1 million.
• Across the five-year window, Net Cash Flow plunged 614.42% in 2022 and soared 5365.04% in 2025, its largest moves.
• Guardant Health's Net Cash Flow stood at -$17.8 million in 2022, then surged by 3892.93% to $675.3 million in 2023, then plunged by 108.43% to -$56.9 million in 2024, then plunged by 250.35% to -$199.4 million in 2025, then surged by 407.01% to $612.2 million in 2026.
• The last three Net Cash Flow figures came in at $612.2 million (Q1 2026), -$199.4 million (Q4 2025), and -$45.4 million (Q3 2025), per Business Quant data.